Connection
Daniel Merrick to Topoisomerase Inhibitors
This is a "connection" page, showing publications Daniel Merrick has written about Topoisomerase Inhibitors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.127 |
|
|
|
-
Haeger SM, Thompson JJ, Kalra S, Cleaver TG, Merrick D, Wang XJ, Malkoski SP. Smad4 loss promotes lung cancer formation but increases sensitivity to DNA topoisomerase inhibitors. Oncogene. 2016 Feb 04; 35(5):577-586.
Score: 0.127